AACR Annual Meeting 2026
April 17–22, 2026 · San Diego · 2418 items
← Next-generation ADCs: payload innovation
ERBB2
0 people · 0 posts
Other cases in this chapter
- T-DXd + pertuzumabPFS HR 0.56 (40.7 vs 26.9 mo)
- olaparib + T-DXdConfirmed PR 42.9%, mDOR 11.2 mo (n=28)
- risvutatugB7-H3 ADC, floor ORR ~47%
- zanidatamab 新辅助No-chemo pCR 30%, HER2 down 56%
- AVA6103 / pan-RAS ADCTricomplex pan-RAS as payload
Floor
No posts under this topic yet.